BRIDGEWATER, N.J., Sept. 29, 2017 /PRNewswire/ -- Nevakar LLC, a privately-held specialty pharmaceutical company developinginnovative therapies within the injectable and ophthalmic space, today announced a collaborative research agreement with Princeton University, using Princeton's proprietary nanoparticle platform
"This research agreement with Princeton University furthers our efforts to develop enhanced and innovative products that leverage novel scientific and technology platforms," said Navneet Puri, Ph.D., founder and chief executive officer of Nevakar.
About Princeton UniversityPrinceton is a not-for-profit institution of higher education dedicated to advancing learning through scholarship, research, and teaching of unsurpassed quality, with an emphasis on undergraduate, and doctoral education that is distinctive among the world's great universities, and with a persuasive commitment to serve the nation and the world.
About NevakarNevakar is a specialty pharmaceutical company focused on therapies within the injectable and ophthalmic space. Our goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently FDA-approved molecules, through intensive R&D and clinical efforts. Nevakar has a comprehensive infrastructure for product development at its New Jersey facilities. More information about Nevakar can be found at www.nevakar.com.
CONTACTSAt Nevakar:Marshall Woodworth Chief Financial Officer(908) [email protected]
At Rx Communications Group:Paula Schwartz(917) [email protected]
View original content:http://www.prnewswire.com/news-releases/nevakar-announces-new-collaborative-research-agreement-with-princeton-university-300528170.html
SOURCE Nevakar LLC
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All